Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03128268 · ClinicalTrials.gov registry record · NA

The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works

A NA study of Cardiac Disease, sponsored by Northwell Health.

Active
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT03128268: Active NA study of Cardiac Disease, sponsored by Northwell Health.

NCT03128268 is a NA study of Cardiac Disease that is active but no longer recruiting, run by Northwell Health. The registered enrollment target is 250 participants, below the 812-participant average among 24 other Cardiac Disease trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03128268, a NA study of Cardiac Disease, is active but no longer recruiting, sponsored by Northwell Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the effectiveness of 4D image acquisition and post-processing with Vios Works for the evaluation of 3D images acquired on GE Magnetic Resonance Imaging scanners. Specifically, the investigators propose to evaluate the following: 1. Image acquisition time using traditional 2D and new 4D processing techniques; 2. Image quality for 2D and 4D processing techniques subjectively 3. Post-processing time for the two techniques. 4. Correlation of overall Left ventricular and right ventricular volumes and functions and aortic and pulmonic flow studies using the two techniques. 5. The study will monitor any changes in patient diagnoses or treatment resulting from any differences in interpretations between the two processes.

Primary Outcome

Investigators will count the number of study outcomes documented that are related to patient treatment.

Conditions Studied

Interventions

  • DEVICE Imaging software for 4 dimensional images for Cardiac MRI

Study Locations (1)

New York

  • Northwell Health Imaging at Greenwich Village: a Division of Lenox Hill Hospital - New York

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2018-02-20
Est. Completion 2023-06-20
Phase NA
Northwell Health

370 total trials

What the registry record for NCT03128268 still lists

NCT03128268 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 812-participant average among 24 other Cardiac Disease trials with a reported enrollment target (69% lower).

The record links to 1 condition, with Cardiac Disease appearing as the primary indexed condition, and to 1 intervention - of which Imaging software for 4 dimensional images for Cardiac MRI is the first listed.

NCT03128268 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03128268 about?

NCT03128268 is a clinical study titled "The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works". This study aims to evaluate the effectiveness of 4D image acquisition and post-processing with Vios Works for the evaluation of 3D images acquired on GE Magnetic Resonance Imaging scanners. Specifically, the investigators propose to evaluate the following: 1. Image acquisition time using traditiona...

What is the current status of trial NCT03128268?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2018-02-20. Estimated completion is 2023-06-20.

What conditions does trial NCT03128268 study?

This clinical trial studies the following conditions: Cardiac Disease.

What interventions are being tested in trial NCT03128268?

The interventions under investigation include: Imaging software for 4 dimensional images for Cardiac MRI (DEVICE).

Who is sponsoring clinical trial NCT03128268?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03128268 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03128268's enrollment target sits among peer trials

250 7th of 24 higher than 18 of 24 other Cardiac Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiac Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03128268, the US trial registry maintained by the National Library of Medicine. NCT03128268 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.